Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ASCT2: a potential cancer drug target.

Literature DB >> 31159623

ASCT2: a potential cancer drug target.

Kanu Wahi¹, Jeff Holst¹.

Abstract

Entities: Disease Gene

Keywords: ASCT2; SLC1A5; cancer; glutamine metabolism; glutamine transport

Year: 2019 PMID： 31159623 DOI： 10.1080/14728222.2019.1627328

Source DB: PubMed Journal: Expert Opin Ther Targets ISSN： 1472-8222 Impact factor: 6.902

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Glutamine Metabolism in Cancer.

Authors: Ting Li; Christopher Copeland; Anne Le
Journal: Adv Exp Med Biol Date: 2021 Impact factor: 2.622

Review 2. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.

Authors: Marianna Nachef; Alaa Kassim Ali; Saeedah Musaed Almutairi; Seung-Hwan Lee
Journal: Front Immunol Date: 2021-04-19 Impact factor: 7.561

3. Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models.

Authors: Abhijit Paul; Rajat Anand; Sonali Porey Karmakar; Surender Rawat; Nandadulal Bairagi; Samrat Chatterjee
Journal: Sci Rep Date: 2021-01-08 Impact factor: 4.379

4. Rational design of ASCT2 inhibitors using an integrated experimental-computational approach.

Authors: Rachel-Ann A Garibsingh; Elias Ndaru; Alisa A Garaeva; Yueyue Shi; Laura Zielewicz; Paul Zakrepine; Massimiliano Bonomi; Dirk J Slotboom; Cristina Paulino; Christof Grewer; Avner Schlessinger
Journal: Proc Natl Acad Sci U S A Date: 2021-09-14 Impact factor: 12.779

ASCT2: a potential cancer drug target.

1. Glutamine Metabolism in Cancer.

Review 2. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.

3. Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models.

4. Rational design of ASCT2 inhibitors using an integrated experimental-computational approach.

Review 5. Targeting Glutamine Addiction in Gliomas.

Review 6. Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas.

Review 7. Cysteine metabolic circuitries: druggable targets in cancer.

8. Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2.

9. The Structure and Mechanism of Drug Transporters.